ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p

Qi, Li*; Yin, Yue; Sun, Mengqi哈尔滨医科大学
Genes & Genomics2023-12DOI: 10.1007/s13258-023-01442-1
3被引6阅读
引用收藏
分享

摘要

BackgroundLung cancer is the most common primary malignant tumor of the lung, and 85% of lung cancer is non-small cell lung cancer (NSCLC). The N6-methyladenosine (m6A) and long noncoding RNAs (lncRNAs) have been widely reported to participate in the development of non-small cell lung cancer.ObjectiveHowever, the potential molecular mechanisms of m6A-regulated lncRNAs in NSCLC still need further investigation.MethodsThe expression levels and the role of lncRNA NEAT1 in NSCLC tissues or cells were measured by RT-qPCR, Western blot, cell counting kit 8 (CCK-8), flow cytometry assay. RNA immunoprecipitation (RIP) was used to measure the levels of m6A modification of NEAT1. Bioinformatics analysis and dual-luciferase reporter gene assay were detected the relationship between miR-361-3p and NEAT1/HMGA1. Mouse xenograft tumor models were established to confirm the effects of lncRNA NEAT1 in vivo.ResultsIn this study, we verified whether m6A-modified lncRNA nuclear enriched abundant transcript 1 (NEAT1) is involved in NSCLC progression via miR-361-3p/HMGA1 axis. Firstly, we found that lncRNA NEAT1 was upregulated in NSCLC, and was associated with a poor survival in NSCLC patients. Methyltransferase like 3 (METTL3)-mediated m6A modification stabilized and upregulated NEAT1 expression. Next, function experiment indicated that depletion of METTL3 and NEAT1 induced cell apoptosis and inhibited cell proliferation, epithelial-mesenchymal transition (EMT). Likewise, in vivo experiments further supported the oncogenic role of NEAT1 in NSCLC. In addition, the molecular mechanism was uncovered in our study, and we found that lncRNA NEAT1 promoted the expression of high-mobility group AT-hook 1 (HMGA1) by sponging miR-361-3p and then promoted tumorigenesis of NSCLC.ConclusionIn conclusion, our findings demonstrated that METTL3-mediated m6A modification accelerated NSCLC progression by regulating the NEAT1/miR-361-3p/HMGA1 axis, which provides important targets for the treatment of NSCLC.

学科与关键词

关键词
Non-small cell lung cancerN6-methyladenosineMethyltransferase like 3Nuclear enriched abundant transcript 1
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Genes & Genomics
发表日期
2023-12
卷期
第 45 卷, 第 12 期
页码
1537-1547
DOI
10.1007/s13258-023-01442-1
语言
ENGLISH
成果收录
SCIE
资助标注
Beijing Health Promotion Association (BJHPA); China Guanghua Technology Foundation

作者

  • Q

    Qi, Li (通讯) (第一作者)

    2 · harbin med univ

  • Y

    Yin, Yue

    2 · harbin med univ

查看全部 3 位作者收起作者
  • S

    Sun, Mengqi

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417